Lab staff prepare small petri dishes, each holding several 1-7 day old embryos, for cells to be extracted from each embryo to test for viability at the Aspire Houston Fertility Institute in vitro fertilization lab in Houston, Texas, on February 27, 2024. Michael Wyke/AP/File

President Donald Trump on Thursday announced an agreement to sell common fertility drugs at steeply reduced prices on TrumpRx, a direct-to-consumer drug platform the White House plans to launch in January 2026.

Under the plan, cost to patients for three in vitro fertilization (IVF) drugs made by EMD Serono, the US arm of German company Merck KGaA, could be reduced by more than 70%, Trump and administration officials said.

The drugs, sold under the brand names Gonal-F, Ovidrel and Cetrotide, currently typically cos

See Full Page